Ranbaxy
-
{
- All
- News
- Videos
-
"They Threatened My Children": Ex-Ranbaxy Promoter's Wife On Tihar Conman
Sukesh Chandrashekhar, a conman who ran his business from behind the bars of Delhi's Tihar Jail, has amassed property worth crores. Rs 200 crore of it has allegedly been extorted from Aditi Singh, wife of former Ranbaxy promoter Shivinder Singh.
-
Ex-Ranbaxy Promoter Malvinder Singh Arrested By Enforcement Directorate
Pharmaceutical giant Ranbaxy Laboratories' ex-promoter Malvinder Singh has been arrested by the Enforcement Directorate in a money laundering case.
-
Delhi High Court Reserves Order On Malvinder Singh's Plea
The Delhi High Court Friday reserved its order on whether to issue notice to the police on former Fortis Healthcare promoter Malvinder Singh's plea seeking quashing of a First Information Report or FIR against him that alleged misappropriation of Religare Finvest Ltd (RFL) funds, causing it a loss to the tune of Rs 2,397 crore.
-
Ranbaxy Ex-Promoters Malvinder, Shivinder Singh Arrested In Fraud Case
Pharmaceutical giant Ranbaxy's ex-promoters Shivinder Singh and his older brother Malvinder Singh were arrested on Thursday in a Rs 740-crore fraud case.
-
Ranbaxy Ex-Promoters Malvinder, Shivinder Singh Raided In Fraud Case
Malvinder Singh and his brother Shivinder Singh, ex-promoters of pharmaceutical giant Ranbaxy, were raided today by the Enforcement Directorate in a Rs 740-crore fraud case. against the former promoters of pharmaceutical company Ranbaxy, Malvinder Mohan Singh and his brother Shivinder Mohan Singh.
-
"Will Send You To Jail," Ranbaxy Singh Brothers Told By Court: 10 Points
The former promoters of pharmaceutical company Ranbaxy, Malvinder Mohan Singh and his brother Shivinder Mohan Singh, were told by the Supreme Court today that they could go to jail for disobeying orders to pay dues to Japanese firm Daiichi Sankyo. "We will go into the issue - why you violated our orders. We will send you to jail. We have given you ...
-
Top Court Orders Status Quo On Sale Of Shares Of Fortis To Malaysian Firm
The Supreme Court on Friday ordered status quo with regard to the sale of controlling stakes of Fortis Healthcare to Malaysian IHH Healthcare Berhad by former Ranbaxy promoters and hospital operators -- Malvinder and Shivinder Singh.
-
Ex-Ranbaxy Promoter Fined Nearly 18 Crore Over Court Disobedience
The Delhi High Court Wednesday directed former Ranbaxy Laboratories Ltd promoter Malvinder Singh to deposit with it 3.5 million Singapore dollars, which he obtained by selling his shares in a company in violation of court's direction.
-
Daiichi Sankyo Asks ED To Probe Singh Brothers' Transactions: A Timeline
Singh brothers lost the case in Singapore arbitration court that ordered them to pay Rs 3,500 crore to Daiichi Sankyo.
-
Sun Pharmaceutical Wins US Approval to Buy Ranbaxy
India's Sun Pharmaceutical Industries Ltd has won US approval to buy Ranbaxy Laboratories Ltd on condition that it sell its interest in a generic antibacterial medicine, the US Federal Trade Commission (FTC) said on Friday.
-
Andhra Pradesh High Court Lifts Stay on Sun Pharma's $3.2 Billion Ranbaxy Takeover
The Andhra Pradesh High Court on Saturday lifted a temporary stay it imposed on generic drugmaker Sun Pharmaceutical Industries Ltd's $3.2 billion takeover of Ranbaxy Laboratories Ltd, a lawyer involved in the case said, paving the way for both companies to complete the deal.
-
India Acts to Repair Reputation as Drugs Exporter
India is launching a campaign to repair its reputation as a global supplier of cheap high-quality drugs, responding to bans imposed by US Food and Drug Administration (FDA) on several suppliers, two top officials said on Tuesday.
-
Unease grows among US doctors over quality of Indian medicines
Some US doctors are becoming concerned about the quality of generic drugs supplied by Indian manufacturers following a flurry of recalls and import bans by the Food and Drug Administration (FDA).
-
Drugs sold by company in the Indian market are safe: Ranbaxy
Ranbaxy Laboratories today insisted drugs sold by it in the Indian market are safe and effective and the company complies with country's regulations, even as the Supreme Court issued a notice to it.
-
US not targeting Indian drug companies: FDA chief
The head of the U.S. Food and Drug Administration said on Friday it was not unduly targeting drug companies in India, which supplies a large portion of drugs used in the U.S., as the agency cracks down on substandard medication from abroad.
-
"They Threatened My Children": Ex-Ranbaxy Promoter's Wife On Tihar Conman
Sukesh Chandrashekhar, a conman who ran his business from behind the bars of Delhi's Tihar Jail, has amassed property worth crores. Rs 200 crore of it has allegedly been extorted from Aditi Singh, wife of former Ranbaxy promoter Shivinder Singh.
-
Ex-Ranbaxy Promoter Malvinder Singh Arrested By Enforcement Directorate
Pharmaceutical giant Ranbaxy Laboratories' ex-promoter Malvinder Singh has been arrested by the Enforcement Directorate in a money laundering case.
-
Delhi High Court Reserves Order On Malvinder Singh's Plea
The Delhi High Court Friday reserved its order on whether to issue notice to the police on former Fortis Healthcare promoter Malvinder Singh's plea seeking quashing of a First Information Report or FIR against him that alleged misappropriation of Religare Finvest Ltd (RFL) funds, causing it a loss to the tune of Rs 2,397 crore.
-
Ranbaxy Ex-Promoters Malvinder, Shivinder Singh Arrested In Fraud Case
Pharmaceutical giant Ranbaxy's ex-promoters Shivinder Singh and his older brother Malvinder Singh were arrested on Thursday in a Rs 740-crore fraud case.
-
Ranbaxy Ex-Promoters Malvinder, Shivinder Singh Raided In Fraud Case
Malvinder Singh and his brother Shivinder Singh, ex-promoters of pharmaceutical giant Ranbaxy, were raided today by the Enforcement Directorate in a Rs 740-crore fraud case. against the former promoters of pharmaceutical company Ranbaxy, Malvinder Mohan Singh and his brother Shivinder Mohan Singh.
-
"Will Send You To Jail," Ranbaxy Singh Brothers Told By Court: 10 Points
The former promoters of pharmaceutical company Ranbaxy, Malvinder Mohan Singh and his brother Shivinder Mohan Singh, were told by the Supreme Court today that they could go to jail for disobeying orders to pay dues to Japanese firm Daiichi Sankyo. "We will go into the issue - why you violated our orders. We will send you to jail. We have given you ...
-
Top Court Orders Status Quo On Sale Of Shares Of Fortis To Malaysian Firm
The Supreme Court on Friday ordered status quo with regard to the sale of controlling stakes of Fortis Healthcare to Malaysian IHH Healthcare Berhad by former Ranbaxy promoters and hospital operators -- Malvinder and Shivinder Singh.
-
Ex-Ranbaxy Promoter Fined Nearly 18 Crore Over Court Disobedience
The Delhi High Court Wednesday directed former Ranbaxy Laboratories Ltd promoter Malvinder Singh to deposit with it 3.5 million Singapore dollars, which he obtained by selling his shares in a company in violation of court's direction.
-
Daiichi Sankyo Asks ED To Probe Singh Brothers' Transactions: A Timeline
Singh brothers lost the case in Singapore arbitration court that ordered them to pay Rs 3,500 crore to Daiichi Sankyo.
-
Sun Pharmaceutical Wins US Approval to Buy Ranbaxy
India's Sun Pharmaceutical Industries Ltd has won US approval to buy Ranbaxy Laboratories Ltd on condition that it sell its interest in a generic antibacterial medicine, the US Federal Trade Commission (FTC) said on Friday.
-
Andhra Pradesh High Court Lifts Stay on Sun Pharma's $3.2 Billion Ranbaxy Takeover
The Andhra Pradesh High Court on Saturday lifted a temporary stay it imposed on generic drugmaker Sun Pharmaceutical Industries Ltd's $3.2 billion takeover of Ranbaxy Laboratories Ltd, a lawyer involved in the case said, paving the way for both companies to complete the deal.
-
India Acts to Repair Reputation as Drugs Exporter
India is launching a campaign to repair its reputation as a global supplier of cheap high-quality drugs, responding to bans imposed by US Food and Drug Administration (FDA) on several suppliers, two top officials said on Tuesday.
-
Unease grows among US doctors over quality of Indian medicines
Some US doctors are becoming concerned about the quality of generic drugs supplied by Indian manufacturers following a flurry of recalls and import bans by the Food and Drug Administration (FDA).
-
Drugs sold by company in the Indian market are safe: Ranbaxy
Ranbaxy Laboratories today insisted drugs sold by it in the Indian market are safe and effective and the company complies with country's regulations, even as the Supreme Court issued a notice to it.
-
US not targeting Indian drug companies: FDA chief
The head of the U.S. Food and Drug Administration said on Friday it was not unduly targeting drug companies in India, which supplies a large portion of drugs used in the U.S., as the agency cracks down on substandard medication from abroad.
